COIN vs SUPN · P/E 64, rev $2.63B vs rev $426.8M
Coinbase Global Inc (COIN) versus Supernus Pharmaceuticals Inc (SUPN) — a side-by-side from cached financials, not a winner call.
Coinbase Global Inc (COIN) is a financial data & stock exchanges company listed on US. It is led by Brian Armstrong.
Supernus Pharmaceuticals Inc (SUPN) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported COIN revenue for 2026-06-30 was $2.63B. Net income was -$753.6M. Revenue was up 86.3% from 2026-03-31 to 2026-06-30. COIN currently screens at market cap $45.84B and trailing P/E 64.2.
Latest reported SUPN revenue for 2026-06-30 was $426.8M. Net income was -$60.7M. SUPN currently screens at market cap $2.53B.
COIN currently screens at market cap $45.84B and trailing P/E 64.2. SUPN currently screens at market cap $2.53B.
Not investment advice. Open the COIN and SUPN stock pages for the full models.
Not investment advice.